Mérieux Equity Partners
Venture capitalParis · Seed–Late Stage · 14 people tracked
Investment thesis
The firm focuses exclusively on the healthcare sector, leveraging deep expertise and a broad industry network. It invests through two strategies: an Innovation platform backing innovative medical solutions from seed to Series B (via Mérieux Innovation 2, with checks of €3m to €15m), and a Buyout platform supporting more established companies (via Mérieux Participations 5, with checks of €20m to €80m, more with co-investment). Both target companies across Europe, ranging from start-ups to established sector leaders.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from curated & public directoriesWhat they invest in
from 14 of 14 portfolio companiesBiotech ×8Medical Devices ×7Healthtech ×6AI & Machine Learning ×4Digital Health ×4Advanced Manufacturing ×2Deep Tech ×2Hardware ×2
HQs:Switzerland×1Germany×1Spain×1Finland×1France×1Netherlands×1
Investments · 14 tracked
founders shown can be your intro pathSwixx BioPharma is a commercialization partner that acts as the local subsidiary for biopharma, OTC, and medical device companies in markets they choose not to enter directly, handling market access, regulatory, and commercial operations without its own R&D or manufacturing.
BiotechHealthtechMedical DevicesBaar, CH
Co-investorsBain Capital Life SciencesHBM PartnersSK Capital Partners
Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks.
AI & Machine LearningBiotechDeep Tech
Co-investorsFirst In VenturesHeran PartnersIllumina VenturesKorys
CorFlow develops the Controlled Flow Infusion (CoFI) System, a catheter-based device for cardiologists to diagnose microvascular obstruction in heart attack (STEMI) patients and deliver therapeutic agents directly into the vasculature during PCI procedures.
HardwareHealthtechMedical Devices
Co-investorsBroadview VenturesLaerdal Million Lives Fund
curea medical GmbH manufactures MPD wound dressings, including SuperCore absorption cores made of cellulose, cotton, and sodium polyacrylate for palliative wound care.
HealthtechMedical Devices
DentalMonitoring offers an AI platform that analyzes smartphone-captured intraoral images to detect and report on 130 oral events, assisting dental professionals with remote observation and monitoring of orthodontic treatments.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsAdelieVitruvian Partners
Health in Code is a genetic diagnostics laboratory that performs full genetic studies, variant interpretation, and clinical-genetic reporting, and develops and manufactures disease diagnostic kits for specialized labs.
BiotechDigital HealthMedical Devices
InnoSyn is a contract development and manufacturing organization (CDMO) and contract research organization focused on small molecule custom synthesis, process optimization, and scalable route scouting, including enzyme engineering and chiral crystallization technologies.
Advanced ManufacturingBiotechDeep Tech
Labquality provides External Quality Assessment (EQA) services for medical laboratories and point-of-care testing sites, offering around 250 EQA products across major fields of laboratory medicine.
Digital HealthHealthtechMedical Devices
Ona provides secure cloud workspaces for running AI coding agents, giving each agent a full cloud development environment with network access, permissions, and runtime controls.
AI & Machine LearningCloud ComputingDeveloper Tools
Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesAlta Life SciencesColumbus Venture Partners+1 more
Ona Therapeutics is a biotechnology company developing first-in-class antibody drug conjugates (ADCs) and antibody therapies targeting the molecular biology of treatment-refractory advanced cancers.
BiotechHealthtech
Co-investorsFund+KorysYsios CapitalAlta Life SciencesAsabys PartnersBpifrance+2 more
Prothea is developing technology to combine lung cancer biopsy and treatment into a single hospital visit, reducing the time from diagnosis to treatment.
BiotechHealthtechMedical Devices
Co-investorsKorysEarlybird Venture CapitalOld College Capital
SeqOne provides a clinical genomics analysis platform for germline and somatic variant interpretation across panels, exomes, and genomes, supporting short and long-read sequencing.
AI & Machine LearningBiotechDigital Health
Nicolas Philippe(Founder)in
Co-investorsSupernova InvestElaia
Exits · 1
IPOs and acquisitions across the tracked portfolioCevaNASDAQ: CEVA
Portfolio news
latest coverage across their companies
Ona Therapeutics · fiercebiotech.com · Aug 12, 2026
Ona · ddw-online.com · Jun 5, 2026
SeqOne · blog.congenica.com · Sep 2, 2025
Frequently asked questions
- How many investments has Mérieux Equity Partners made?
- Mérieux Equity Partners has 11 tracked investments, including 1 dated in the last 24 months.
- What stage does Mérieux Equity Partners invest at?
- Mérieux Equity Partners invests at the Seed, Series A, Series B, Growth, Late Stage stages.
- What is Mérieux Equity Partners's typical check size?
- Mérieux Equity Partners typically writes checks of $3.2M – $86M.
- What sectors does Mérieux Equity Partners focus on?
- Mérieux Equity Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Mérieux Equity Partners located?
- Mérieux Equity Partners is headquartered in Paris, FR.
- Does Mérieux Equity Partners lead rounds?
- Yes, Mérieux Equity Partners leads investment rounds.
- Who does Mérieux Equity Partners co-invest with?
- Mérieux Equity Partners most often shares deals with Korys, Broadview Ventures, Heran Partners, among 9 tracked co-investors.
Images
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

















.jpeg)